Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 72 of 179 for:    "Lymphomatoid Granulomatosis"

Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00994500
Recruitment Status : Completed
First Posted : October 14, 2009
Last Update Posted : July 2, 2013
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2011
  Study Completion Date : No date given